News + Filings Transactions
|
Goldberg Mark Alan
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
09/30/2023 | GLYCOMIMETICS INC | GLYC | Grant | Common stock | 9.2k | $1.50 | $13.8k | | 09/30/2023 |
06/30/2023 | ImmunoGen, Inc. | IMGN | Grant | Common Stock | 894 | $18.87 | $16.9k | | 06/30/2023 |
06/14/2023 | ImmunoGen, Inc. | IMGN | Grant | Restricted Stock Unit | 13.1k | $0.00 | $0 | | 06/14/2023 |
06/14/2023 | ImmunoGen, Inc. | IMGN | Grant | Stock Option (right to buy) | 19.6k | $0.00 | $0 | | 06/14/2023 |
12/30/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 3.4k | $0.00 | $0 | | 12/30/2022 |
09/30/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 3.5k | $0.00 | $0 | | 09/30/2022 |
06/30/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 3.8k | $0.00 | $0 | | 06/30/2022 |
06/23/2022 | Aceragen, Inc. | IDRA | Grant | | 26k | $0.46 | $11.9k | | 06/23/2022 |
06/21/2022 | Blueprint Medicines Corp | BPMC | Grant | Common Stock | 2.6k | $0.00 | $0 | | 06/21/2022 |
06/21/2022 | Blueprint Medicines Corp | BPMC | Grant | Stock Option (Right to Buy) | 5.3k | $50.64 | $268.4k | | 06/21/2022 |
06/15/2022 | ImmunoGen, Inc. | IMGN | Grant | Stock Option (right to buy) | 44k | $3.37 | $148.3k | | 06/15/2022 |
06/15/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 15k | $0.00 | $0 | | 06/15/2022 |
05/18/2022 | GLYCOMIMETICS INC | GLYC | Grant | Stock Option (right to buy) | 21k | $0.60 | $12.6k | | 05/18/2022 |
03/31/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 3.2k | $0.00 | $0 | | 03/31/2022 |
03/31/2022 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 3.5k | $0.00 | $0 | | 03/31/2022 |
03/03/2022 | Blueprint Medicines Corp | BPMC | Purchase | Common Stock | 5k | $59.98 | $299.9k | | 03/03/2022 |
12/31/2021 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 1.8k | $0.00 | $0 | | 12/31/2021 |
09/30/2021 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 2.4k | $0.00 | $0 | | 09/30/2021 |
06/30/2021 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 2k | $0.00 | $0 | | 06/30/2021 |
06/16/2021 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 15k | $0.00 | $0 | | 06/16/2021 |
06/16/2021 | ImmunoGen, Inc. | IMGN | Grant | Stock Option (right to buy) | 44k | $6.77 | $297.9k | | 06/16/2021 |
06/08/2021 | Aceragen, Inc. | IDRA | Grant | | 26k | $1.31 | $34.1k | | 06/08/2021 |
06/02/2021 | Blueprint Medicines Corp | BPMC | Grant | Common Stock | 2.2k | $0.00 | $0 | | 06/02/2021 |
06/02/2021 | Blueprint Medicines Corp | BPMC | Grant | Stock Option (Right to Buy) | 4.5k | $87.13 | $392.1k | | 06/02/2021 |
05/18/2021 | GLYCOMIMETICS INC | GLYC | Grant | | 5.2k | $0.00 | $0 | | 05/18/2021 |
05/18/2021 | GLYCOMIMETICS INC | GLYC | Grant | Stock Option (right to buy) | 10.5k | $2.55 | $26.8k | | 05/18/2021 |
04/01/2021 | Aceragen, Inc. | IDRA | Grant | Common Stock | 10.5k | $1.32 | $13.9k | | 04/01/2021 |
03/31/2021 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 1.7k | $0.00 | $0 | | 03/31/2021 |
01/04/2021 | Aceragen, Inc. | IDRA | Grant | Common Stock | 3.5k | $4.02 | $13.9k | | 01/04/2021 |
12/31/2020 | ImmunoGen, Inc. | IMGN | Grant | Deferred Share Unit | 2.1k | $0.00 | $0 | | 12/31/2020 |
12/24/2020 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 5.5k | $125.00 | $681.9k | | 12/24/2020 |
12/24/2020 | Blueprint Medicines Corp | BPMC | Exercise | Stock Option (Right to Buy) | 5.5k | $28.15 | $153.6k | | 12/24/2020 |
12/18/2020 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 5.5k | $120.00 | $654.5k | | 12/18/2020 |
12/18/2020 | Blueprint Medicines Corp | BPMC | Exercise | Stock Option (Right to Buy) | 5.5k | $28.15 | $153.5k | | 12/18/2020 |
12/11/2020 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 5.5k | $115.00 | $627.3k | | 12/11/2020 |
|
|